The majority of Danish breast cancer survivors on adjuvant endocrine therapy have clinically relevant sexual dysfunction: a cross-sectional study

被引:13
|
作者
Fogh, Mia [1 ]
Hojgaard, Astrid [2 ]
Rotbol, Charlotte Birkmose [3 ]
Jensen, Anders Bonde [1 ]
机构
[1] Aarhus Univ Hosp, Dept Oncol, Blvd 99, DK-8200 Aarhus N, Denmark
[2] Aalborg Univ Hosp, Sexol Ctr, Aalborg, Denmark
[3] Aalborg Univ Hosp, Dept Oncol, Aalborg, Denmark
关键词
Sexual health; sexual dysfunction; breast cancer; endocrine therapy; side effects; late effects; QUALITY-OF-LIFE; FUNCTION INDEX FSFI; AROMATASE INHIBITORS; MENOPAUSAL SYMPTOMS; BODY-IMAGE; LONG-TERM; FOLLOW-UP; WOMEN; DISTRESS; VALIDATION;
D O I
10.1080/0284186X.2020.1813326
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Impairments in sexual function are common among breast cancer survivors (BCSs), particularly in BCSs receiving adjuvant endocrine therapy (AET). Whether these impairments cause distress, thus qualifying for a more clinically relevant diagnosis of sexual dysfunction (SD), is inadequately described among BCSs and represents an important research gap. Hence, the primary aim of this study was to estimate the prevalence of clinically relevant SD, in this context: impairments with associated distress, and to identify factors associated with SD among BCSs on AET. Secondly, to explore the extent of distress caused by specific impairments in sexual function. Materials and methods In this cross-sectional study of BCSs on adjuvant treatment with endocrine therapy for at least three months, participants completed an online survey comprising standardized measures of sexual and psychosocial function. Female Sexual Function Index (FSFI) and Sexual Complaint Screener - Women (SCS-W) were used to asses clinically relevant SD. Multiple regression analyses were performed to identify factors significantly associated with SD. Results In total, 333 BCSs with a mean age of 58.7 years were included in the study, of whom 227 were sexually active. Among sexually active BCSs, 134 (59%) met the criteria for having clinically relevant SD, of whom 78 (58%) perceived cancer treatment as the primary reason for their sexual problems. Factors associated with SD included vaginal dryness (adjusted OR= 2.25, 95% CI: 1.52-3.34,p < .01) and psychological well-being (adjusted OR= 1.11, 95% CI: 1.03-1.18,p < .01). Age was not related to neither prevalence of SD nor the level of distress caused by any impairment, with exception of low sexual desire. Pain in relation to intercourse was the most distressing impairment. Conclusion SD was highly prevalent among sexually active BCSs on AET. Sexual health is important to address independent of the woman's age.
引用
收藏
页码:61 / 68
页数:8
相关论文
共 50 条
  • [1] Fear of cancer recurrence in South Korean survivors of breast cancer who have received adjuvant endocrine therapy: a cross-sectional study
    Park, Seul Ki
    Min, Yul Ha
    [J]. FRONTIERS IN PSYCHOLOGY, 2023, 14
  • [2] Sexual dysfunction among breast cancer survivors in adjuvant endocrine treatment
    Andersen, Mia F.
    Hojgaard, Astrid
    Rotboel, Charlotte B.
    Jensen, Anders Bonde
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [3] Association of sexual attitudes with sexual dysfunction and sexual distress among Chinese breast cancer survivors: a cross-sectional study
    Yan, Rui
    Wang, Jiwei
    Yu, Jinming
    [J]. SUPPORTIVE CARE IN CANCER, 2023, 31 (03)
  • [4] Association of sexual attitudes with sexual dysfunction and sexual distress among Chinese breast cancer survivors: a cross-sectional study
    Rui Yan
    Jiwei Wang
    Jinming Yu
    [J]. Supportive Care in Cancer, 2023, 31
  • [5] Vaginal and sexual health of hormone-receptor positive breast cancer survivors on oral endocrine therapy: A cross-sectional study
    Skitch, Amy
    Moskalewicz, Alexandra
    Scime, Samantha
    Nisenbaum, Rosane
    Lee, Ronita
    Haq, Rashida
    Dzerko, Christine
    Brezden-Masley, Christine
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [6] Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer
    Baumgart, Juliane
    Nilsson, Kerstin
    Evers, Anneli Stavreus
    Kallak, Theodora Kunovac
    Poromaa, Inger Sundstrom
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2013, 20 (02): : 162 - 168
  • [7] Sexual Dysfunction in Breast Cancer Survivors Is it Surgical Modality or Adjuvant Therapy?
    Gandhi, Christy
    Butler, Elizabeth
    Pesek, Sarah
    Kwait, Rebecca
    Edmonson, David
    Raker, Christina
    Clark, Melissa A.
    Stuckey, Ashley
    Gass, Jennifer
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (06): : 500 - 506
  • [8] Marital status and sexual health in breast cancer survivors: A cross-sectional study
    Matos, A. L. V.
    Teixeira, S.
    Ponte, S.
    Fonseca, V.
    Fernandes, L.
    Graca, J. A.
    Neves, M. T.
    Alves, F.
    Placido, A.
    Miranda, H.
    Martins, A.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S958 - S958
  • [9] Sexual Dysfunction among Gynaecological Cancer Survivors: A Descriptive Cross-Sectional Study in Malaysia
    Muhit, Akmal Muzamir Mohamad
    Woon, Luke Sy-Cherng
    Nor, Nik Sumayyah Nik Mhd
    Sidi, Hatta
    Kalok, Aida Hani Mohd
    Kampan, Nirmala Chandralega
    Shafiee, Mohamad Nasir
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (23)
  • [10] Comparison of distress in breast cancer survivors treated with different adjuvant endocrine therapies: a single-centre cross-sectional study
    Kus, Tulay
    Aktas, Gokmen
    Ekici, Hatice
    Elboga, Gulcin
    [J]. PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2017, 27 (03) : 277 - 283